Target raised to $3.00 Simon is a tireless communicator for Tlry, fy '25 guidance revenue $950m-$1B, most well positioned and diversified globally in this sector. With some anticipated relaxation of the excise tax and the logical US legalization of medical marijuana (Trump will exercise the tax grab) adding to my position today on market weakness was a no brainer. GLTALs
Tilray (NASDAQ:TLRY) Price Target Raised to $3.00 at Canaccord Genuity Group. Tilray (NASDAQ:TLRY - Get Free Report) had its target price lifted by research analysts at Canaccord Genuity Group from $2.00 to $3.00 in a report released on Monday,BayStreet.CA reports. The firm presently has a "buy" rating on the stock.